AVEO Oncology, an LG Chem company ("AVEO"), is a biopharmaceutical company that is trying to provide differentiated solutions to improve cancer patients lives, presented two posters during the 2025 ...

Reported encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with androgen receptor ...

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

With an award-winning PhD in Probiotics and as a leading Research Fellow at King’s College London, it's fair to say I know a thing or two about gut health and which supplements to take to boost yours.

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

A new study suggests that daily taxifolin intake may support weight loss in older adults, possibly through brown fat ...

DelveInsight's Transmucosal Drugs Market Insights report provides the current and forecast market analysis, individual ...

Meghan Markle has unveiled the rebranding of her lifestyle company, "As Ever", which supersedes her former company, American ...

Chronic pain patients received medically unnecessary injections from Pain MD as part of a decade-long fraud scheme.

Meghan Markle's new brand logo is loaded with symbolism. Inside the deeper meaning of what the Duchess of Sussex chose for the As Ever crest.

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for our fiscal '25 third-quarter video earnings webcast. Before we go inside to ...

The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...